Norges Bank
FUSN

Norges Bank’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Norges Bank’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50,000
Closed -$588K – 2206
2020
Q4 		$588K Hold
50,000
– – ﹤0.01% 2070
2020
Q3 		$601K Hold
50,000
– – ﹤0.01% 2070
2020
Q2 		$874K Buy
+50,000
New +$871K ﹤0.01% 2020

Other funds holding FUSN

JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank's FUSN Position: Q1 2021 in Review

Norges Bank sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q1 2021, closing a stake of 50,000 shares — an estimated $588K sold.

Norges Bank first reported a position in FUSN in Q2 2020 and held it in 3 quarters. The position peaked at $874K in Q2 2020. 38 funds tracked by Wall St. Rank hold FUSN as of Q1 2021.

  • Norges Bank reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q1 2021 after selling out during the quarter.
  • Norges Bank sold 50,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q1 2021, an estimated $588K.
  • Norges Bank first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 3 quarters.
  • Norges Bank's Fusion Pharmaceuticals Inc. Common Shares position peaked at $874K in Q2 2020.
  • 38 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q1 2021.

Based on Norges Bank's 13F filing for Q1 2021, filed 7 May 2021.